Retatrutide is a novel peptide compound developed for research into obesity and diabetes treatment. As a GLP-1/GIP/glucagon tri-agonist, it demonstrates enhanced efficacy compared to single-agonist peptides.
The peptide works through multiple mechanisms to potentially promote weight loss while preserving muscle mass. Research suggests it may help regulate blood sugar levels, reduce appetite, and increase energy expenditure.
This high-purity Retatrutide powder is provided in research-grade quality for laboratory use only. Each batch undergoes rigorous quality control testing to ensure consistent purity and performance.
Retatrutide is presented as a lyophilized white powder in sterile vials. The product maintains stability when stored properly at recommended temperatures.
Potential research applications include metabolic studies, obesity research, diabetes treatment investigations, and body composition analysis. The tri-agonist properties make it particularly interesting for studying combined metabolic pathways.
For optimal stability, store unopened vials at -20°C. Reconstituted peptide should be used immediately or stored at 2-8°C for short-term use. Avoid repeated freeze-thaw cycles.
This product is for research use only, not for human consumption. Handle using appropriate laboratory safety protocols including gloves, protective eyewear, and lab coats. Keep out of reach of children and pets.